Literature DB >> 17356847

Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology.

Dominique Bataille1.   

Abstract

Many peptide hormones implicated in the regulation of intermediary metabolism arise from larger precursors called prohormones. These precursors are cut into pieces by proprotein convertases, more precisely those called prohormone convertases (PCs) that cleave at the C terminus of basic doublets. The remaining basic amino acids are eliminated by a specialized carboxypeptidase, leading to the active hormone. This processing may provide, from a single precursor, several peptides with different biological activities depending on the site(s) of cleavage on the precursor. When the processing is tissue-specific, this mechanism allows to produce, from a single protein, different sets of hormones depending on the tissue considered, leading to novel regulatory processes. The archetype of such a pluripotent prohormone in the field of intermediary metabolism is pro-glucagon that, when cut by PC1 in intestinal L cells, produces four different peptides with different specificities [glicentin, oxyntomodulin (OXM), glucagon-like peptide-1, and glucagon-like peptide-2], whereas, when cut by PC2 in the alpha cells of the endocrine pancreas, glucagon is produced and, through the supplementary action of NRD convertase, a fragment of glucagon (miniglucagon) with original properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17356847     DOI: 10.1007/s00109-007-0167-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  113 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1.

Authors:  R Mouchantaf; H L Watt; T Sulea; N G Seidah; H Alturaihi; Y C Patel; U Kumar
Journal:  Regul Pept       Date:  2004-08-15

3.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

Review 4.  GIP or not GIP? That is the question.

Authors:  Timothy J Kieffer
Journal:  Trends Pharmacol Sci       Date:  2003-03       Impact factor: 14.819

5.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.

Authors:  M Tang-Christensen; P J Larsen; R Göke; A Fink-Jensen; D S Jessop; M Møller; S P Sheikh
Journal:  Am J Physiol       Date:  1996-10

6.  Isolation, purification, and characterization of gamma-lipotropic hormone from sheep pituitary glands.

Authors:  M Chrétien; C H Li
Journal:  Can J Biochem       Date:  1967-07

7.  Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.

Authors:  N Dachicourt; P Serradas; D Bailbé; M Kergoat; L Doaré; B Portha
Journal:  J Endocrinol       Date:  1997-11       Impact factor: 4.286

8.  Glucagon-like peptide-1 inhibits glucagon-induced glycogenolysis in perivenous hepatocytes specifically.

Authors:  Yoshihiro Ikezawa; Keiichi Yamatani; Hiroshi Ohnuma; Makoto Daimon; Hideo Manaka; Hideo Sasaki
Journal:  Regul Pept       Date:  2003-03-28

9.  Separation of insulin signaling into distinct GLUT4 translocation and activation steps.

Authors:  Makoto Funaki; Paramjeet Randhawa; Paul A Janmey
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

Authors:  Catherine L Dakin; Caroline J Small; Rachel L Batterham; Nicola M Neary; Mark A Cohen; Michael Patterson; Mohammad A Ghatei; Stephen R Bloom
Journal:  Endocrinology       Date:  2004-03-04       Impact factor: 4.736

View more
  10 in total

Review 1.  Processing of peptide and hormone precursors at the dibasic cleavage sites.

Authors:  Mohamed Rholam; Christine Fahy
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

2.  Fasting Circulating Glicentin Increases After Bariatric Surgery.

Authors:  Juliette Raffort; Patricia Panaïa-Ferrari; Fabien Lareyre; Pascale Bayer; Pascal Staccini; Patrick Fénichel; Giulia Chinetti
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

3.  Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.

Authors:  Gayatri Mukherjee; Rodolfo J Chaparro; Jennifer Schloss; Carla Smith; Christopher D Bando; Teresa P DiLorenzo
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 4.  Evolving function and potential of pancreatic alpha cells.

Authors:  Violeta Stanojevic; Joel F Habener
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-10-08       Impact factor: 4.690

5.  Expression of Secretogranin III in Chicken Endocrine Cells: Its Relevance to the Secretory Granule Properties of Peptide Prohormone Processing and Bioactive Amine Content.

Authors:  Hiroshi Gomi; Satomi Morikawa; Naoki Shinmura; Hiroaki Moki; Tadashi Yasui; Azuma Tsukise; Seiji Torii; Tsuyoshi Watanabe; Yoshinori Maeda; Masahiro Hosaka
Journal:  J Histochem Cytochem       Date:  2015-02-11       Impact factor: 2.479

6.  Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2.

Authors:  Liora S Katz; Yvan Gosmain; Eric Marthinet; Jacques Philippe
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

Review 7.  Insights on glicentin, a promising peptide of the proglucagon family.

Authors:  Juliette Raffort; Fabien Lareyre; Damien Massalou; Patrick Fénichel; Patricia Panaïa-Ferrari; Giulia Chinetti
Journal:  Biochem Med (Zagreb)       Date:  2017-06-15       Impact factor: 2.313

8.  Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme-linked immunosorbent assay.

Authors:  Toshihiro Matsuo; Jun-Ichiro Miyagawa; Yoshiki Kusunoki; Masayuki Miuchi; Takashi Ikawa; Takafumi Akagami; Masaru Tokuda; Tomoyuki Katsuno; Akira Kushida; Takashi Inagaki; Mitsuyoshi Namba
Journal:  J Diabetes Investig       Date:  2015-08-24       Impact factor: 4.232

9.  Modified Western blotting for insulin and other diabetes-associated peptide hormones.

Authors:  Naoyuki Okita; Yoshikazu Higami; Fumio Fukai; Masaki Kobayashi; Miku Mitarai; Takao Sekiya; Takashi Sasaki
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

10.  Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.